137 related articles for article (PubMed ID: 1414338)
41. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
Prager RL; Dunn EL; Kirsh MM; Penner JA
Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
[TBL] [Abstract][Full Text] [Related]
42. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
43. Microscopic polyangiitis associated with marked systemic bleeding tendency caused by disseminated intravascular coagulation.
Saito T; Tsuchiya M; Shikata C; Yamaguchi H; Miyata S; Matsuo S; Ishizawa S; Yoshimura K
Intern Med; 2003 Sep; 42(9):850-5. PubMed ID: 14518675
[TBL] [Abstract][Full Text] [Related]
44. Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates.
Chistolini A; Mazzucconi MG; Tirindelli MC; La Verde G; Ferrari A; Mandelli F
Acta Haematol; 1990; 83(3):163-5. PubMed ID: 2109459
[TBL] [Abstract][Full Text] [Related]
45. Supportive management strategies for disseminated intravascular coagulation. An international consensus.
Squizzato A; Hunt BJ; Kinasewitz GT; Wada H; Ten Cate H; Thachil J; Levi M; Vicente V; D'Angelo A; Di Nisio M
Thromb Haemost; 2016 May; 115(5):896-904. PubMed ID: 26676927
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery.
Hsu JT; Chen HM; Chiu DF; Chen JC; Huang CJ; Hwang TL; Jan YY; Chen MF
J Formos Med Assoc; 2004 Sep; 103(9):678-84. PubMed ID: 15361940
[TBL] [Abstract][Full Text] [Related]
47. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
48. [Activation of coagulation and fibrinolysis in patients with abdominal true aortic aneurysm associated with disseminated intravascular coagulation].
Akaike M; Yokoi K; Wada M; Sebe T; Shigekiyo T; Kawai H; Saito S
Kokyu To Junkan; 1993 Mar; 41(3):267-70. PubMed ID: 8469833
[TBL] [Abstract][Full Text] [Related]
49. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia.
Van Dam PA; Renier M; Baekelandt M; Buytaert P; Uyttenbroeck F
Obstet Gynecol; 1989 Jan; 73(1):97-102. PubMed ID: 2909047
[TBL] [Abstract][Full Text] [Related]
50. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257
[TBL] [Abstract][Full Text] [Related]
51. Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies.
Levi M; de Jonge E; van der Poll T; ten Cate H
Semin Thromb Hemost; 2001 Dec; 27(6):569-75. PubMed ID: 11740680
[TBL] [Abstract][Full Text] [Related]
52. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
53. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
[TBL] [Abstract][Full Text] [Related]
54. [Intravascular coagulation and severe hepatic failure in infants].
Odievre M; Hadchouel P; Dupuy JM; Alagille D
Arch Fr Pediatr; 1976 Jan; 33(1):31-6. PubMed ID: 985030
[TBL] [Abstract][Full Text] [Related]
55. Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
Taenaka N; Shimada Y; Kawai M; Yoshiya I; Kosaki G
Anaesthesia; 1981 Apr; 36(4):389-93. PubMed ID: 6787945
[TBL] [Abstract][Full Text] [Related]
56. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
57. Antithrombin III patterns in disseminated intravascular coagulation.
Bick RL; Bick MD; Fekete LF
Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
[TBL] [Abstract][Full Text] [Related]
58. A short contemporary history of disseminated intravascular coagulation.
Levi M; van der Poll T
Semin Thromb Hemost; 2014 Nov; 40(8):874-80. PubMed ID: 25377321
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
Mertens R; Peschgens T; Granzen B; Heimann G
Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
[TBL] [Abstract][Full Text] [Related]
60. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
